The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM)

被引:3
|
作者
Stedman, Mike [1 ]
Rea, Rustam [2 ]
Duff, Christopher J. [3 ,4 ]
Livingston, Mark [5 ]
McLoughlin, Katie [6 ]
Wong, Louise [6 ]
Brown, Stephen [6 ]
Grady, Katherine [6 ]
Gadsby, Roger [7 ]
Gibson, John M. [6 ,8 ,9 ]
Paisley, Angela [6 ]
Fryer, Anthony A. [3 ,4 ]
Heald, Adrian H. [6 ,8 ,9 ]
机构
[1] Res Consortium, Andover, England
[2] Oxford Ctr Diabet Endocrinol & Metab, Oxford, England
[3] Univ Hosp North Midlands NHS Trust, North Midlands & Cheshire Pathol Serv, Dept Clin Biochem, Stoke On Trent, Staffs, England
[4] Keele Univ, Sch Med, Keele, Staffs, England
[5] Walsall Manor Hosp, Black Country Pathol Serv, Walsall, W Midlands, England
[6] Salford Royal Hosp, Salford, Lancs, England
[7] Univ Warwick, Warwick Med Sch, Warwick, W Midlands, England
[8] Univ Manchester, Sch Med, Manchester, Lancs, England
[9] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
关键词
blood glucose; diabetes education; HbA1c; monitoring; patient experience; type; 2; diabetes; GLYCATED HEMOGLOBIN;
D O I
10.1002/edm2.302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Finger prick blood glucose (BG) monitoring remains a mainstay of management in people with type 2 diabetes (T2DM) who take sulphonylurea (SU) drugs or insulin. We recently examined patient experience of BG monitoring in people with type 1 diabetes (T1DM). There has not been any recent comprehensive assessment of the performance of BG monitoring strips or the patient experience of BG strips in people with T2DM in the UK. Methods An online self-reported questionnaire containing 44 questions, prepared following consultation with clinicians and patients, was circulated to people with T2DM. 186 responders provided completed responses (25.5% return rate). Fixed responses were coded numerically (eg not confident = 0 fairly confident = 1). Results Of responders, 84% were treated with insulin in addition to other agents. 75% reported having had an HbA1c check in the previous 6 months. For those with reported HbA1c >= 65 mmol/mol, a majority of people (70%) were concerned or really concerned about the shorter term consequences of running a high HbA1c This contrasted with those who did not know their recent HbA1c, of whom only 33% were concerned/really concerned and those with HbA1c <65 mmol/mol of whom 35% were concerned. Regarding BG monitoring/insulin adjustment, only 25% of responders reported having sufficient information with 13% believing that the accuracy and precision of their BG metre was being independently checked. Only 9% recalled discussing BG metre accuracy when their latest metre was provided and only 7% were aware of the International Standardisation Organisation (ISO) standards for BG metres. 77% did not recall discussing BG metre performance with a healthcare professional. Conclusion The group surveyed comprised engaged people with T2DM but even within this group there was significant variation in (a) awareness of shorter term risks, (b) confidence in their ability to implement appropriate insulin dosage (c) awareness of the limitations of BG monitoring technology. There is clearly an area where changes in education/support would benefit many.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Life Expectancy of Individuals with Type 2 Diabetes Mellitus (T2DM) in the United States
    Kianmehr, Hamed
    Yang, Shuang
    Fonseca, Vivian
    Shi, Lizheng
    Brown, Joshua D.
    Guo, Yi
    Shao, Hui
    [J]. DIABETES, 2020, 69
  • [32] Glycaemic control and pregnancy outcomes in women with Type 2 diabetes mellitus (T2DM)
    Pang, W. H.
    Tan, Z.
    Todd, D.
    Halliday, M.
    Gill, F.
    Rhoads, M.
    Sathiskumar, P.
    Gallagher, A.
    de Chazal, R.
    Lawrence, I. G.
    [J]. DIABETIC MEDICINE, 2008, 25
  • [33] Characteristics of Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Therapy with Canagliflozin
    Martin, Silas C.
    Henk, Henry J.
    Chow, Wing
    [J]. DIABETES, 2014, 63 : A307 - A307
  • [34] The improvement of sulforaphane in type 2 diabetes mellitus (T2DM) and related complications: A review
    Wang, Mengjiao
    Chen, Min
    Guo, Rui
    Ding, Yangyang
    Zhang, Haihui
    He, Yuanqing
    [J]. Trends in Food Science and Technology, 2022, 129 : 397 - 407
  • [35] Regional effects of type 2 diabetes mellitus (T2DM) on grey matter atrophy
    Moran, C.
    Phan, T. G.
    Beare, R.
    Chen, J.
    Blizzard, L.
    Venn, A.
    Greenaway, T.
    Munch, G.
    Forbes, J.
    Pearson, S.
    Srikanth, V
    [J]. AUSTRALASIAN JOURNAL ON AGEING, 2012, 31 : 34 - 34
  • [36] Characteristics of a large urban pediatric population with type 2 diabetes mellitus (T2DM)
    Katz, LEL
    Norris, R
    Weinzimer, SA
    Jawad, AF
    Preis, CM
    McKnight, H
    Murphy, KM
    [J]. DIABETES, 2001, 50 : A380 - A380
  • [37] Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM)
    Souto, Selma B.
    Souto, Eliana B.
    Braga, Daniel C.
    Medina, Jose L.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (07) : 653 - 661
  • [38] Epidemiology of Diabetic Nephropathy in Adults with Type 2 Diabetes Mellitus (T2DM) in the US
    Chaudhari, Paresh
    Zhou, Zhou
    Yang, Hongbo
    Fang, Anna
    Wu, Eric
    Seifeldin, Raafat
    [J]. DIABETES, 2016, 65 : A387 - A387
  • [39] Predictors of depressive symptoms in youth at risk for type 2 diabetes mellitus (T2DM)
    Holl, Marita G.
    Jefferson, Vanessa
    Womack, Julie A.
    Grey, Margaret
    [J]. DIABETES, 2006, 55 : A424 - A424
  • [40] MobiDiabet: Mobile Telemonitoring System for Patients with Type 2 Diabetes Mellitus (T2DM)
    Alcala Juarez, Anakaren
    Hernandez Villegas, Manuel Alejandro
    Dominguez, Eduardo Lopez
    Hernandez Velazquez, Yesenia
    Dominguez Isidro, Saul
    Ovando Diego, Liliana
    Hernandez Sanchez, Olivia
    De La Calleja, Jorge
    Pomares Hernandez, Saul Eduardo
    Medina Nieto, Maria Auxilio
    [J]. APPLIED SCIENCES-BASEL, 2020, 10 (22): : 1 - 36